- Home
- HRTX vs GLO Comparison
HRTX vs GLO Comparison
Compare HRTX & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- GLO
- Stock Information
- Founded
- HRTX 1983
- GLO 2006
- Country
- HRTX United States
- GLO United States
- Employees
- HRTX N/A
- GLO N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- GLO Finance/Investors Services
- Sector
- HRTX Health Care
- GLO Finance
- Exchange
- HRTX Nasdaq
- GLO Nasdaq
- Market Cap
- HRTX 242.0M
- GLO 245.9M
- IPO Year
- HRTX 1987
- GLO N/A
- Fundamental
- Price
- HRTX $1.19
- GLO $5.86
- Analyst Decision
- HRTX Strong Buy
- GLO
- Analyst Count
- HRTX 2
- GLO 0
- Target Price
- HRTX $4.50
- GLO N/A
- AVG Volume (30 Days)
- HRTX 1.5M
- GLO 170.5K
- Earning Date
- HRTX 11-04-2025
- GLO 01-01-0001
- Dividend Yield
- HRTX N/A
- GLO 11.38%
- EPS Growth
- HRTX N/A
- GLO N/A
- EPS
- HRTX N/A
- GLO N/A
- Revenue
- HRTX $149,694,000.00
- GLO N/A
- Revenue This Year
- HRTX $10.62
- GLO N/A
- Revenue Next Year
- HRTX $12.99
- GLO N/A
- P/E Ratio
- HRTX N/A
- GLO N/A
- Revenue Growth
- HRTX 9.78
- GLO N/A
- 52 Week Low
- HRTX $1.04
- GLO $4.08
- 52 Week High
- HRTX $2.68
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- HRTX 39.59
- GLO 64.72
- Support Level
- HRTX $1.16
- GLO $5.62
- Resistance Level
- HRTX $1.25
- GLO $5.71
- Average True Range (ATR)
- HRTX 0.07
- GLO 0.08
- MACD
- HRTX -0.01
- GLO 0.01
- Stochastic Oscillator
- HRTX 13.64
- GLO 92.86
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.